Oklo (OKLO) Stock Soars 13% Following Major NRC Regulatory Approval

Key Takeaways

• Oklo shares climbed more than 13% following NRC clearance of its Principal Design Criteria topical report for the Idaho-based Aurora powerhouse reactor
• The NRC used a fast-track review timeline, marking progress toward simplified licensing procedures for next-generation reactors
• Texas Capital Securities maintained its Buy recommendation with a $120 price objective after the announcement
• The company will report Q1 2026 financial results on May 12, providing another potential catalyst
• Fellow nuclear stocks including NuScale and Nano Nuclear posted gains alongside Oklo’s rally

Shares of Oklo experienced a sharp uptick exceeding 13% during Tuesday’s midday session after the United States Nuclear Regulatory Commission granted approval for a critical design framework related to the company’s Aurora powerhouse reactor being developed in Idaho.

Oklo Inc., OKLO

The equity peaked at $79.03 during intraday activity before settling near $78.45.

The regulatory body greenlit Oklo’s Principal Design Criteria topical report using an expedited evaluation timeline. This accelerated approach demonstrates the commission’s commitment to establishing streamlined authorization processes for advanced nuclear technologies.

This PDC clearance establishes the core safety standards, reliability benchmarks, and operational specifications that will inform subsequent licensing submissions and reactor engineering efforts. The approval also allows the document to serve as a reference point for upcoming applications, eliminating redundant regulatory assessments.

Analyst Maintains Bullish Stance

Following the regulatory news, Texas Capital Securities analyst Nate Pendleton reaffirmed a Buy recommendation and $120 valuation target on Oklo. Pendleton characterized the PDC clearance as “another incremental step forward” while highlighting the “increasingly efficient regulatory path for advanced reactor solutions.”

The stock maintains a “Moderate Buy” consensus rating, bolstered by recent analyst coverage additions from Tigress Financial and HSBC.

The expedited NRC evaluation process connects directly to executive directives signed by President Trump in May 2025, designed to accelerate pathways for advanced nuclear energy initiatives. The approach also corresponds with the ADVANCE Act, legislation promoting streamlined deployment of innovative nuclear technologies.

Skeptics of Oklo have historically pointed to potential regulatory obstacles as a primary risk factor. Tuesday’s NRC determination weakens that bearish argument, although additional approvals remain necessary before commercial operations can commence.

As a pre-revenue enterprise, regulatory milestones serve as critical indicators of operational progress for investors monitoring the company’s development.

Broader Nuclear Industry Benefits

The positive momentum extended beyond Oklo. NuScale Power and Nano Nuclear also posted gains as nuclear energy stocks experienced consecutive sessions of strength. General market conditions also provided support, with the S&P 500 advancing 1.08%, the Dow climbing 1.07%, and the Nasdaq rising 1.46%.

In addition to the Idaho facility, Oklo is collaborating with Meta Platforms on a 1.2 gigawatt nuclear energy initiative in Ohio designed to power Meta’s regional data infrastructure.

Oklo has scheduled its Q1 2026 earnings release and conference call for May 12.

The post Oklo (OKLO) Stock Soars 13% Following Major NRC Regulatory Approval appeared first on Blockonomi.